Answer
Women of childbearing potential receiving pegcetacoplan should use effective contraception during treatment and for at least 8 weeks after the last dose.
Sources for this answer
- ASPAVELI 1080 mg solution for infusionSwedish Orphan Biovitrum Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 9Document updated
Sources checked